# Virginia HB483: Prescription Drug Affordability Board; established.

Virginia HB483, Prescription Drug Affordability Board; established., is a 2026 Regular Session House bill sponsored by Karrie K. Delaney (Democratic); status vetoed, last action 2026-05-19 (Vetoed by Governor) (as of 2026-10-11).

- Canonical: https://policyrisk.com/state-bill/VA-HB483-2026
- As of: 2026-10-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: Virginia HB483
- State: Virginia
- Session: 2026 Regular Session
- Title: Prescription Drug Affordability Board; established.
- Status: vetoed
- Chamber: House
- Introduced: 2026-01-12
- Last action: 2026-05-19, Vetoed by Governor
- Sponsor: Karrie K. Delaney (Democratic)
- Cosponsors: 0
- Touches household money: no
- Roll calls: 13 (283 yes, 75 no in all)
- Economic provisions PRIA read: 0

## Summary

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to SB 271.

## Bill overview

No economic impacts identified for this bill.

## Sponsors and cosponsors

- Sponsor: Karrie K. Delaney (Democratic), House

## Roll call votes

| Date | Chamber | Motion | Result | Yes | No | Other |
| --- | --- | --- | --- | --- | --- | --- |
| 2026-03-12 | House | Senate substitute agreed to by House | pass | 87 | 11 |   |
| 2026-03-11 | Senate | Finance and Appropriations Substitute agreed to | pass | 0 | 0 |   |
| 2026-03-11 | Senate | Passed Senate with substitute | pass | 34 | 6 |   |
| 2026-03-11 | Senate | Commerce and Labor Substitute rejected | pass | 0 | 0 |   |
| 2026-03-10 | Senate | Constitutional reading dispensed Block Vote (on 2nd reading) | pass | 37 | 0 |   |
| 2026-03-10 | Senate | Passed by for the day Block Vote (Voice Vote) | pass | 0 | 0 |   |
| 2026-03-09 | Senate | Reported from Finance and Appropriations with substitute | pass | 10 | 4 |   |
| 2026-03-09 | Senate | Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations | pass | 12 | 3 |   |
| 2026-02-13 | House | Read third time and passed House | pass | 61 | 33 |   |
| 2026-02-09 | House | Reported from Appropriations | pass | 17 | 5 |   |
| 2026-02-06 | House | Subcommittee recommends reporting | pass | 6 | 1 |   |
| 2026-01-29 | House | Reported from Labor and Commerce with amendment(s) and referred to Appropriations | pass | 14 | 8 |   |
| 2026-01-27 | House | Subcommittee recommends reporting with amendment(s) and referring to Appropriations | pass | 5 | 4 |   |

## Actions (47)

- 2026-05-19: Vetoed by Governor (Governor)
- 2026-05-19: Governor's Veto Received by House (House)
- 2026-04-23: Passed by for the day (House)
- 2026-04-23: Governor's Action Deadline 11:59 p.m., May 23, 2026 (Governor)
- 2026-04-23: Communicated to Governor (House)
- 2026-04-22: Passed by for the day (House)
- 2026-04-13: Governor's recommendation received by House (Governor)
- 2026-03-31: Fiscal Impact Statement from Department of Planning and Budget (HB483) (House)
- 2026-03-31: Governor's Action Deadline 11:59 p.m., April 13, 2026 (Governor)
- 2026-03-31: Enrolled Bill communicated to Governor on March 31, 2026 (House)
- 2026-03-31: Signed by Speaker (House)
- 2026-03-30: Bill text as passed House and Senate (HB483ER) (House)
- 2026-03-30: Enrolled (House)
- 2026-03-30: Signed by President (Senate)
- 2026-03-23: Fiscal Impact Statement from Department of Planning and Budget (HB483) (House)
- 2026-03-12: Senate substitute agreed to by House (87-Y 11-N 0-A) (House)
- 2026-03-11: Passed Senate with substitute (34-Y 6-N 0-A) (Senate)
- 2026-03-11: Finance and Appropriations Substitute agreed to (Senate)
- 2026-03-11: Commerce and Labor Substitute rejected (Senate)
- 2026-03-11: Engrossed by Senate - committee substitute (Senate)
- 2026-03-11: Read third time (Senate)
- 2026-03-10: Passed by for the day Block Vote (Voice Vote) (Senate)
- 2026-03-10: Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A) (Senate)
- 2026-03-10: Committee substitute printed 26109533D-S2 (Senate)
- 2026-03-10: Rules suspended (Senate)
- 2026-03-09: Committee substitute printed 26109394D-S1 (Senate)
- 2026-03-09: Senate committee offered (Senate)
- 2026-03-09: Reported from Finance and Appropriations with substitute (10-Y 4-N) (Senate)
- 2026-03-09: Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (12-Y 3-N) (Senate)
- 2026-02-17: Fiscal Impact Statement from Department of Planning and Budget (HB483) (House)
- 2026-02-16: Referred to Committee on Commerce and Labor (Senate)
- 2026-02-16: Constitutional reading dispensed (on 1st reading) (Senate)
- 2026-02-13: Read third time and passed House (61-Y 33-N 0-A) (House)
- 2026-02-12: Engrossed by House as amended (House)
- 2026-02-12: committee amendments agreed to (House)
- 2026-02-12: Read second time (House)
- 2026-02-11: Read first time (House)
- 2026-02-09: Reported from Appropriations (17-Y 5-N) (House)
- 2026-02-06: Subcommittee recommends reporting (6-Y 1-N) (House)
- 2026-01-30: Assigned HAPP sub: Health & Human Resources (House)
- 2026-01-29: Reported from Labor and Commerce with amendment(s) and referred to Appropriations (14-Y 8-N) (House)
- 2026-01-27: Fiscal Impact Statement from Department of Planning and Budget (HB483) (House)
- 2026-01-27: House subcommittee offered (House)
- 2026-01-27: Subcommittee recommends reporting with amendment(s) and referring to Appropriations (5-Y 4-N) (House)
- 2026-01-19: Assigned HCL sub: Subcommittee #1 (House)
- 2026-01-12: Referred to Committee on Labor and Commerce (House)
- 2026-01-12: Prefiled and ordered printed; Offered 01-14-2026 26104953D (House)

## Bill text

- Veto Explanation, 2026-05-19: [HTML](https://lis.blob.core.windows.net/files/1225795.HTML)
- Substitute, 2026-04-14: [HTML](https://lis.blob.core.windows.net/files/1219394.HTML), [PDF](https://lis.blob.core.windows.net/files/1219393.PDF)
- Gov Recommendation, 2026-04-13: [HTML](https://lis.blob.core.windows.net/files/1219129.HTML)
- Enrolled, 2026-03-30: [HTML](https://lis.blob.core.windows.net/files/1213457.HTML), [PDF](https://lis.blob.core.windows.net/files/1213456.PDF)
- Substitute, 2026-03-10: [HTML](https://lis.blob.core.windows.net/files/1203882.HTML), [PDF](https://lis.blob.core.windows.net/files/1203881.PDF)
- Substitute, 2026-03-09: [HTML](https://lis.blob.core.windows.net/files/1200512.HTML), [HTML](https://lis.blob.core.windows.net/files/1201633.HTML), [PDF](https://lis.blob.core.windows.net/files/1200511.PDF), [PDF](https://lis.blob.core.windows.net/files/1201632.PDF)
- Engrossed, 2026-02-12: [HTML](https://lis.blob.core.windows.net/files/1138418.HTML), [PDF](https://lis.blob.core.windows.net/files/1138417.PDF)
- Amendment, 2026-01-30: [HTML](https://lis.blob.core.windows.net/files/1105074.HTML)
- Amendment, 2026-01-28: [HTML](https://lis.blob.core.windows.net/files/1098971.HTML)
- Amendment, 2026-01-27: [HTML](https://lis.blob.core.windows.net/files/1098377.HTML)
- Introduced, 2026-01-12: [HTML](https://lis.blob.core.windows.net/files/1084632.HTML), [PDF](https://lis.blob.core.windows.net/files/1084631.PDF)

## Related bills

- HB5: Employment; paid sick leave, civil penalties. (signed)
- SB199: Employment; paid sick leave, civil penalties. (signed)
- HB95: Va. Residential Landlord and Tenant Act; landlord remedies, noncompliance with rental agreement. (signed)
- HB1393: Electric utilities; pilot program for energy assistance and weatherization for certain individuals. (signed)
- HB834: Virginia Residential Landlord and Tenant Act; fire or casualty damage, termination by landlord. (signed)
- HB675: Protection of employees; coercion or threat based on immigration status, civil penalty. (signed)

## Sources
- [Veto Explanation (HTML)](https://lis.blob.core.windows.net/files/1225795.HTML)
- [Substitute (HTML)](https://lis.blob.core.windows.net/files/1219394.HTML)
- [Substitute (PDF)](https://lis.blob.core.windows.net/files/1219393.PDF)
- [Gov Recommendation (HTML)](https://lis.blob.core.windows.net/files/1219129.HTML)
- [Enrolled (HTML)](https://lis.blob.core.windows.net/files/1213457.HTML)
- [Enrolled (PDF)](https://lis.blob.core.windows.net/files/1213456.PDF)
- [Substitute (HTML)](https://lis.blob.core.windows.net/files/1203882.HTML)
- [Substitute (PDF)](https://lis.blob.core.windows.net/files/1203881.PDF)
- [Substitute (HTML)](https://lis.blob.core.windows.net/files/1200512.HTML)
- [Substitute (HTML)](https://lis.blob.core.windows.net/files/1201633.HTML)
- [Substitute (PDF)](https://lis.blob.core.windows.net/files/1200511.PDF)
- [Substitute (PDF)](https://lis.blob.core.windows.net/files/1201632.PDF)
- [Engrossed (HTML)](https://lis.blob.core.windows.net/files/1138418.HTML)
- [Engrossed (PDF)](https://lis.blob.core.windows.net/files/1138417.PDF)
- [Amendment (HTML)](https://lis.blob.core.windows.net/files/1105074.HTML)
- [Amendment (HTML)](https://lis.blob.core.windows.net/files/1098971.HTML)
- [Amendment (HTML)](https://lis.blob.core.windows.net/files/1098377.HTML)
- [Introduced (HTML)](https://lis.blob.core.windows.net/files/1084632.HTML)
- [Introduced (PDF)](https://lis.blob.core.windows.net/files/1084631.PDF)

## Related
- [HB5: Employment; paid sick leave, civil penalties.](https://policyrisk.com/state-bill/VA-HB5-2026)
- [SB199: Employment; paid sick leave, civil penalties.](https://policyrisk.com/state-bill/VA-SB199-2026)
- [HB95: Va. Residential Landlord and Tenant Act; landlord remedies, noncompliance with…](https://policyrisk.com/state-bill/VA-HB95-2026)
- [HB1393: Electric utilities; pilot program for energy assistance and weatherization for…](https://policyrisk.com/state-bill/VA-HB1393-2026)
- [HB834: Virginia Residential Landlord and Tenant Act; fire or casualty damage, terminat…](https://policyrisk.com/state-bill/VA-HB834-2026)
- [HB675: Protection of employees; coercion or threat based on immigration status, civil…](https://policyrisk.com/state-bill/VA-HB675-2026)
- [Virginia bills](https://policyrisk.com/states/virginia/bills)
- [Virginia state hub](https://policyrisk.com/states/virginia)
- [All state legislation](https://policyrisk.com/state-bills)

Source: PRIA, https://policyrisk.com/state-bill/VA-HB483-2026 (as of 2026-10-11).
